相关实验视频

Updated: Jan 9, 2026

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate

Published on: July 10, 2018

选择性向NMDA受体的亚型-一个强大的新化合物出现了

Hiro Furukawa¹

¹W.M. Keck Structural Biology Laboratory, Cold Spring Harbor Laboratory , Cold Spring Harbor, NY, USA.

The Journal of general physiology

|December 3, 2025

概括

研究人员开发了UCM-101,它是一种对N-甲基-D-酸盐受体 (NMDARs) 的强效和选择性GluN2A抑制剂. 这种新化合物为神经科学研究提供了一个有前途的工具,并为神经系统疾病提供了潜在的治疗方法.

科学领域:

神经药理学神经药理学
分子神经科学分子神经科学
药物发现药物发现药物发现

背景情况:

向N-甲基-D-酸盐受体 (NMDARs) 对于理解谷氨基酶信号传递和开发神经系统疾病治疗方法至关重要.
在NMDAR调制中实现亚型选择性是神经药理学的重大挑战.

研究的目的:

描述UCM-101的发展和特征,一种新的GluN2A选择性NMDAR抑制剂.
研究UCM-101亚型选择性和作用机制的结构基础.
评估UCM-101作为研究工具和治疗支架的潜力.

主要方法:

一个弱活性脚手架 (TCN-213) 的化学优化,以产生UCM-101.
生物化学测试以确定功效 (IC50) 和对NMDAR亚型的选择性.
进行X射线结晶学 (1.7 Å),以阐明连接体结合域 (LBD) 结构.
位点定向突变发生,以确定选择性决定因素.
在海马片中进行电生理学记录,以评估突触电流的功能抑制.

主要成果:

对于GluN1/2A NMDARs,UCM-101显示出高强度 (110 nM IC50) 和选择性 (高达118倍).
晶体结构显示UCM-101结合到一个新的全位 ("UCM子位") 在一个扩展的构造,稳定不活跃的受体状态.
突变酶确定了关键残留物 (GluN2A V529,M788,T797),这些残留物有助于选择性,与其他调节器结合部位不同.
在海马片片中,UCM-101有效地抑制了NMDAR介导的突触电流,并在三异体受体上表现出类似的功效.

结论:

UCM-101在开发强效和选择性的GluN2A NMDAR抑制剂方面取得了重大进展.
该研究验证了GluN2A选择性抑制的机制框架,并扩大了对全调节的结构理解.
UCM-101作为一种有价值的研究工具,也是未来针对NMDAR相关疾病的治疗开发的有希望的支架.

更多相关视频

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

Examination of Anatomical Features of Retinal Ganglion Cells Under N-methyl-D-aspartic Acid (NMDA)-induced Excitotoxicity

Examination of Anatomical Features of Retinal Ganglion Cells Under N-methyl-D-aspartic Acid (NMDA)-induced Excitotoxicity

Published on: September 19, 2025

相关概念视频

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.

Antiepileptic Drugs: Glutamate Antagonists

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...